Effect of up-regulation of Shh-Gli1 signaling pathway on radioresistance and cell cycle in human esophageal cancer cell line Eca109
10.3969/j.issn.1000-4718.2018.05.005
- VernacularTitle:上调人食管癌Eca109细胞Shh-Gli1信号通路对放射抗拒性及细胞周期的影响
- Author:
Jin-Jing YU
1
;
Yu-Lin HE
;
Jia-Qi LIU
;
Fei YAO
;
Qun LIU
;
Hui LONG
;
Qing-Ming WU
Author Information
1. 武汉科技大学医学院
- Keywords:
Esophageal cancer;
Radioresistance;
Cell cycle;
Shh-Gli1 signaling pathway
- From:
Chinese Journal of Pathophysiology
2018;34(5):799-803
- CountryChina
- Language:Chinese
-
Abstract:
AIM:To investigate the relationship between Sonic Hedgehog(Shh)signaling pathway and cell cycle and radioresistance of esophageal cancer by up-regulating Gli1,a key factor in Shh signaling pathway.METHODS:The human esophageal cancer cell line Eca 109 was transfected with plasmid to induce Gli 1 over-expression,which served as Eca109-ox-Gli1 group.In addition, Eca109 cells transfected with empty plasmid served as negative control group and the untreated Eca109 cells were used as normal control group.The expression of Gli1 was confirmed by real-time PCR and Western blot.The radiosensitivity of the cells in the 3 groups was determined by colony formation assay.The effect of irra-diation on the cell cycle was analyzed by flow cytometry.RESULTS:The expression of Gli1 in Eca109-ox-Gli1 group was higher than that in the other 2 groups(P<0.05).The survival fraction at dose of 2 Gy in Eca109-ox-Gli1 group was high-er than that in normal control group, indicating that the radioresistance of the Eca 109 cells transfected with Gli1 plasmid was increased.The cells in Eca109-ox-Gli1 group showed higher S phase proportion than that in normal control group and negative control group(P<0.01).After irradiation at dose of 6 Gy,all cells in the 3 groups found that the cell cycle was arrested at G2/M phase,while the cells in normal control group showed higher G 2/M phase proportion than that in Eca109-ox-Gli1 group(P<0.01).CONCLUSION: The up-regulation of Gli1 may enhance the radioresistance of esophageal cancer by regulating the cell cycle.
